working 24/7 for truth and honesty
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
LOL well to be precise I did not post that interview. BUT it s profoundly disappointing that only one side of that point is made, LL did indeed mistakenly claim that the FDA mandated the crossover, however the official SAP said::
per the demand of investigators and patients
it was necessary to include a crossover option in the Protocol in order to recruit and retain
patients.
I believe in airing all sides of the argument LOL LOL
So the fda is just like the irs , the doj the dod lol lol
thanks, note that this presentation in June , 4 years after publication still says dccrap is not a solution
nah, not really as there are already approved therapies
yes she was way way behind a bunch of other oncologists
actually he made neither point
No thanks I have seen and heard from those sources .
Yes I sure am lol lol
Trustworthy ???? Nah not sources that for example like to falsely claim others agree with them .
Yes I agree one must be careful about what Is posted . For example there are posts that claim the trial was a success lol imagine that lol
Lol it is a civil suit and not filed by the sec but just another greedy law firm
Because the efficacy is not proven
Actually ridiculous is the most accurate
Probably because 1. No interest in an unproven product 2 the stock will decline in the future
says nothing about drug development. Sure they support the science supporting drug development, but as I have explained they are not regulators
That Is not even in the mission of the nih
lol jams oncology lol lol
Thanks for that about regulators but as I have explained previously NIH is not a regulator
LOL the flawed P3, the s called peer review by a second rate journal no thanks LOL
LOL so, LP seems to have never launched a pharma product. Hmmmmmmm that is what I thought
agree:
NORTHWEST BIOTHERAPEUTICS INC NWBO on OTC
• Insider transactions
No insider transaction filings for this company in last 365 days
what pharmaceutical products has LP launched that would
qualify her to teach such a course
Those who can , do. Those who cant teach. GBShaw
nwbo follows that philosophy religiously. Their mantra is if we say the trial was a success often enough people will believe it
wow, sec. doj fbi. cia congressional hearings , this is gonna be fun! maybe LP will be on Jerry Springer LOL LOL
LOL of course I was not talking about that . But the MMs involved are partying tonight
by the way changing the subject does not mean we will forget LPs "experience" LOL LOL
well, WE know YIKES!!!!!!
we are WELL aware of the background of LP. YIKES!!!!!
As I have explained previously the FDA does not approve individual studies. Upon submission of an INDm id the agency has not places a hold, the company can proceed with clincial trials, The company i s NOT bound by any guidance the FDA may have offered. The FDA may place a hold on an IND or one or more clinical studies if they are concerned about patient safety.
This FDA document may help
https://www.fda.gov/drugs/investigational-new-drug-ind-application/ind-application-procedures-clinical-hold
disclosure about what?
probably lots of attorneys looking for defamation
me too lol lol
thanks for thr reminder, here is what he said
same data
ah so she is in the tippy top , but not the top as claimed LOL LOL
thanks for asking
Neuro Oncol
. 2018 Sep 3;20(10):1283-1284. doi: 10.1093/neuonc/noy125.
First results on the DCVax phase III trial: raising more questions than providing answers
Wolfgang Wick 1, Martin J van den Bent 2
yes but she is not eve close to the top, thanks for proving she is not the best
well well well, there is Wick, and we now what he thinks of that crap study
https://expertscape.com/au/glioblastoma/Wick%2C+W